For instance, short courses of anti-VEGF therapy, low-dose radiotherapy, or epigenetic modulators could increase MHC expression on tumor cells, enhance chemokine secretion, and improve immune cell trafficking to the tumor site [231]. The gene discussed is VEGFA; the disease is neoplasm.